NCT05231798: Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
- State
- Under way
- Phase
- Phase 2
- People
- 30 planned
- Started
- 19 Aug 2021
- Primary completion
- 30 Apr 2027
- Arms
- Down Syndrome
- Results
- None posted
- 19 Aug 2021: Trial started
- 9 Feb 2022: Trial registered